The diagnostic medicine group Fleury 🇧🇷FLRY3) announced this Thursday that it closed an agreement to sell 51% of Papaiz to Clidec, controlled by Odontoprev, which already has a stake in the business, for 19.2 million reais.
Papaiz, which operates dental imaging diagnostics, had in the last 12 months until October net revenue of 29.5 million reais.
“The company follows its service portfolio strategy in solutions with full potential for integration and formation of an ecosystem for the coordination of care in primary, secondary and tertiary care through the businesses that the company has developed and acquired in diagnostic medicine and new links ”, said Fleury in a material fact.
Source: Moneytimes
I am an author and journalist with a focus on market news. I have worked for a global news website for the past two years, writing articles on a range of topics relating to the stock market. My work has been published in international publications and I have delivered talks at both academic institutions and business conferences around the world.
